Tu1892 TOFACITINIB FOR ULCERATIVE COLITIS: RESULTS OF THE ICC REGISTRY, A NATIONWIDE PROSPECTIVE OBSERVATIONAL COHORT STUDY
Vince Biemans(Radboud University Nijmegen), Jasmijn A M Sleutjes(Erasmus MC), Adriaan A. van Bodegraven(Maastricht University Medical Centre), Mark Löwenberg(Amsterdam University Medical Centers), Bas Oldenburg(University Medical Center Utrecht), Annemarie C. de Vries(Erasmus MC), Frank Hoentjen(Radboud University Nijmegen), Alexander Bodelier(Amphia Ziekenhuis), Andrea v. Meulen - de Jong, Carmen S. Horjus Talabur Horje(Rijnstate Hospital), Gerard Dijkstra(University Medical Center Groningen), Rinse K. Weersma(University Medical Center Groningen), Tessa E H Römkens(Jeroen Bosch Ziekenhuis), Rachel West(Sint Franciscus Gasthuis), Nidhi Srivastava, Jeroen M. Jansen(OLVG), Jildou Hoekstra(Amphia Ziekenhuis), Nanne K.H. de Boer, Fiona van Schaik
Cited by 1
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity
|Science|2016|2k
The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids
|Circulation Research|2015|784